\ New diabetes clinical trial: NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes - Bestiny

Translate

Breaking

Tuesday, 8 September 2020

New diabetes clinical trial: NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes

Published on: September 07, 2020 at 09:30PM
Condition:   Suspected or Confirmed COVID-19
Interventions:   Drug: NBT-NM108;   Other: Usual Care Only
Sponsors:   Notitia Biotechnologies Company;   University of South Florida;   Rutgers University
Not yet recruiting
https://ift.tt/2EZMefv

No comments:

Post a Comment

Nothing happens without a Reason
Make Something out of it.